| Literature DB >> 31302149 |
Enzo Tramontano1, Bart Tarbet2, Jessica R Spengler3, Katherine Seley-Radtke4, Chris Meier5, Robert Jordan6, Zlatko Janeba7, Brian Gowen2, Brian Gentry8, José A Esté9, Mike Bray10, Graciela Andrei11, Luis M Schang12.
Abstract
The 32nd International Conference on Antiviral Research (ICAR), sponsored by the International Society for Antiviral Research (ISAR), was held in Baltimore, Maryland, USA, on May 12-15, 2019. This report gives an overview of the conference on behalf of the Society. It provides a general review of the meeting and awardees, summarizing the presentations, and their main conclusions from the perspective of researchers active in many different areas of antiviral research and development. As in past years, ICAR promoted and showcased the most recent progress in antiviral research, and continued to foster collaborations and interactions in drug discovery and development. The 33rd ICAR will be held in Seattle, Washington, USA, March 30th-April 3rd, 2020.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31302149 PMCID: PMC7105345 DOI: 10.1016/j.antiviral.2019.104550
Source DB: PubMed Journal: Antiviral Res ISSN: 0166-3542 Impact factor: 5.970